Obesity drug fears investigated (BBC news online, 25 August 2009)

26 Aug 2009


The anti-obesity drug Orlistat has been linked with liver damage. The US Food and Drug Administration are now reviewing the safety of the drug, which works by blocking fat absorption in the body.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story


Top stories

Website Refresh!
20 Dec 2024

Most read